Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The multiple sclerosis microbiome?

Literature DB >> 28251132

The multiple sclerosis microbiome?

Helen Tremlett¹, Emmanuelle Waubant².

Abstract

Entities: Disease

Year: 2017 PMID： 28251132 PMCID： PMC5326653 DOI： 10.21037/atm.2017.01.63

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

13 in total

Review 1. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis.

Authors: Kylynda C Bauer; Kelsey E Huus; B Brett Finlay
Journal: Cell Microbiol Date: 2016-03-31 Impact factor: 3.715

2. Gut microbiota in early pediatric multiple sclerosis: a case-control study.

Authors: Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Feng Zhu; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal: Eur J Neurol Date: 2016-05-13 Impact factor: 6.089

3. Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Authors: Brandi L Cantarel; Emmanuelle Waubant; Christel Chehoud; Justin Kuczynski; Todd Z DeSantis; Janet Warrington; Arun Venkatesan; Claire M Fraser; Ellen M Mowry
Journal: J Investig Med Date: 2015-06 Impact factor: 2.895

4. The treatment-naive microbiome in new-onset Crohn's disease.

Authors: Subra Kugathasan; Lee A Denson; Dirk Gevers; Yoshiki Vázquez-Baeza; Will Van Treuren; Boyu Ren; Emma Schwager; Dan Knights; Se Jin Song; Moran Yassour; Xochitl C Morgan; Aleksandar D Kostic; Chengwei Luo; Antonio González; Daniel McDonald; Yael Haberman; Thomas Walters; Susan Baker; Joel Rosh; Michael Stephens; Melvin Heyman; James Markowitz; Robert Baldassano; Anne Griffiths; Francisco Sylvester; David Mack; Sandra Kim; Wallace Crandall; Jeffrey Hyams; Curtis Huttenhower; Rob Knight; Ramnik J Xavier
Journal: Cell Host Microbe Date: 2014-03-12 Impact factor: 21.023

5. Gut microbiota composition and relapse risk in pediatric MS: A pilot study.

Authors: Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal: J Neurol Sci Date: 2016-02-20 Impact factor: 3.181

Review 6. The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.

Authors: Ruth Ann Marrie; Nadia Reider; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary R Cutter; Stephen C Reingold; Jeffrey Cohen
Journal: Mult Scler Date: 2014-12-23 Impact factor: 6.312

7. Alterations of the human gut microbiome in multiple sclerosis.

Authors: Sushrut Jangi; Roopali Gandhi; Laura M Cox; Ning Li; Felipe von Glehn; Raymond Yan; Bonny Patel; Maria Antonietta Mazzola; Shirong Liu; Bonnie L Glanz; Sandra Cook; Stephanie Tankou; Fiona Stuart; Kirsy Melo; Parham Nejad; Kathleen Smith; Begüm D Topçuolu; James Holden; Pia Kivisäkk; Tanuja Chitnis; Philip L De Jager; Francisco J Quintana; Georg K Gerber; Lynn Bry; Howard L Weiner
Journal: Nat Commun Date: 2016-06-28 Impact factor: 14.919

8. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.

Authors: Sachiko Miyake; Sangwan Kim; Wataru Suda; Kenshiro Oshima; Masakazu Nakamura; Takako Matsuoka; Norio Chihara; Atsuko Tomita; Wakiro Sato; Seok-Won Kim; Hidetoshi Morita; Masahira Hattori; Takashi Yamamura
Journal: PLoS One Date: 2015-09-14 Impact factor: 3.240

9. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

Authors: Kareem Rashid Rumah; Jennifer Linden; Vincent A Fischetti; Timothy Vartanian
Journal: PLoS One Date: 2013-10-16 Impact factor: 3.240

10. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production.

Authors: Ujjala Ghoshal; Ratnakar Shukla; Deepakshi Srivastava; Uday C Ghoshal
Journal: Gut Liver Date: 2016-11-15 Impact factor: 4.519

5 in total

The multiple sclerosis microbiome?

Review 1. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis.

2. Gut microbiota in early pediatric multiple sclerosis: a case-control study.

3. Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

4. The treatment-naive microbiome in new-onset Crohn's disease.

5. Gut microbiota composition and relapse risk in pediatric MS: A pilot study.

Review 6. The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.

7. Alterations of the human gut microbiome in multiple sclerosis.

8. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.

9. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

10. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production.

Review 1. The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings.

Review 2. The sex-specific interaction of the microbiome in neurodegenerative diseases.

Review 3. Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases.

Review 4. Gut Microbiota in Neurological Disorders.

5. Alterations of the Fecal Microbiota in Chinese Patients With Multiple Sclerosis.